Brought to you by 
MorphoSys nets $20.1mm in IPO
13 Jan 2000
Executive Summary
MorphoSys AG (drug discovery and combinatorial biology) raised net proceeds of $20.1mm in its initial public offering of 843,040 ordinary shares at $27 each on the Neuer Market. Selling shareholders offered additional shares.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MorphoSys nets $20.1mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice